Form 4: Astrana Health COO/CFO Reports Stock Transactions

Chandan Basho, COO and CFO of Astrana Health, Inc., reported transactions involving common stock, including the surrender of shares for tax withholding and details on unvested restricted stock and units.

Summary

• Chandan Basho, COO and CFO of Astrana Health, Inc. (ASTH), reported a transaction on April 2, 2026.
• 2,092 shares of common stock were surrendered to offset tax withholding obligations related to vested restricted stock units.
• The transaction price was $25.05 per share.
• Following this transaction, Basho beneficially owns 171,635 shares of common stock.
• The filing also details unvested restricted stock and restricted stock units with various vesting schedules extending into 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents a standard insider transaction and compensation disclosure without significant strategic or financial performance implications.

Positives

• The COO and CFO continues to hold a significant beneficial ownership of 171,635 shares.
• Vesting schedules for restricted stock and units indicate continued incentive alignment with the company's performance and employee retention.

Negatives

• The surrender of shares for tax withholding, while a standard practice, represents a reduction in direct shareholding.

Risks

• Vesting of restricted stock and units is subject to continuous employment with the Issuer, implying a risk of forfeiture if employment ceases before vesting dates.

Future Outlook

The filing details future vesting schedules for restricted stock and restricted stock units, indicating ongoing equity awards tied to continued employment.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions and do not typically provide strategic insights. The details on restricted stock unit vesting are standard for executive compensation packages in the healthcare and technology sectors.

Stakeholder Impact

• Shareholders: The transaction itself is a routine tax-related event for the executive and does not directly impact share value, though it reduces the executive's direct holdings by a small amount.

Next Steps

• Continued vesting of restricted stock and restricted stock units according to the outlined schedules.
• Potential future transactions by Chandan Basho as per SEC regulations.

Key Dates

Keywords

Form 4, SEC Filing, Insider Transaction, Astrana Health, ASTH, Chandan Basho, COO, CFO, Stock Transaction, Restricted Stock Units, Tax Withholding